MODERNA, INC.

MRNA · NASDAQ

Biological Product (except Diagnostic) Manufacturing · US

Moderna, Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA.

ESG Overview

Overall: BBB (High)

E: AS: BBG: BB

ESG grades from public dataset.

ESG data: Public Company ESG Ratings (CC BY-NC-SA 4.0)

Market Data

Price $44.29 -1.65 (-3.59%)

Market Cap$18.22B

P/E Ratio—

EPS$—

52W High$59.55

52W Low$22.28

Beta1.05

Data from Finnhub · Updated May 1, 2026